Thromboembolic Disease
Found 5 free book(s)
IMHA disease in canines – diagnosis and treatment
www.vettimes.co.ukA mild thrombocytopenia may indicate secondary thromboembolic disease. A severe thrombocytopenia is consistent with Evans syndrome, where the platelets are also targeted by the immune system. Serum biochemistry is usually normal or shows changes secondary to dehydration and/or tissue
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eudisease activity. Three or more consecutive, monthly injections may be needed. Treatment may then be continued with a treat-and-extend regimen with gradually increased treatment ... Systemic adverse events including non-ocular haemorrhages and arterial thromboembolic events have
Lists of medicinal products for rare diseases in Europe*
www.orpha.netChronic thromboembolic pulmonary hypertension (CTEPH), persistent or recurrent CTEPH after surgical treatment, to improve exercise capacity. As monotherapy or in combination with endothelin receptor antagonists, for the treatment of adult patients with pulmonary arterial hypertension (PAH) with WHO Functional Class (FC) II to III to improve
Prior authorization and step therapy coverage criteria
www.bcbsm.com1. Diagnosis of Still’s disease, including adult-onset Still’s disease (AOSD) and systemic juvenile idiopathic arthritis (sJIA) 2. Age ≥ 2 years old . 3. Trial and treatment failure of one of the following therapies: methotrexate, leflunomide, glucocorticoids, NSAIDs . OR . 1. Diagnosis of giant cell arteritis 2. Age ≥ 18 years old
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euVenous thromboembolic events were reported in 5.3% of patients treated with abemaciclib plus fulvestrant or aromatase inhibitors, compared to 0.8% of patients treated with placebo plus fulvestrant or aromatase inhibitors. Patients should be monitored for signs and symptoms of deep vein thrombosis